Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 145 for pancreatic cancer

Edit search filters
  1. Phase II Randomized Trial Of MFOLFIRINOX +/- Ramucirumab In Advanced Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  2. Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel In Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  3. A Phase 2 Study Of VS-7375 In Patients With KRAS G12D-Mutated Pancreatic Cancer

    Jacksonville, FL, Rochester, MN

  4. BPM31510 Administered Intravenously With Or Without Gemcitabine In Advanced Pancreatic Cancer Patients

    Scottsdale/Phoenix, AZ

  5. A Study Of AbGn-107 In Patients With Gastric, Colorectal, Or Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  6. A Study Of Rucaparib In Patients With Pancreatic Cancer And A Known Deleterious BRCA Mutation

    Rochester, MN

  7. Safety And Efficacy Of Combination Listeria/GVAX Pancreas Vaccine In The Pancreatic Cancer Setting

    Rochester, MN

  8. Dignity Therapy/Life Plan In Patients With Pancreatic Or Advanced Lung Cancer

    Rochester, MN

  9. Stereotactic Adaptive Radiation Therapy Of Borderline Resectable Pancreatic Cancer An Individualized Approach

    Rochester, MN

  10. M402 In Combination With Nab-Paclitaxel And Gemcitabine In Pancreatic Cancer

    Rochester, MN

.

Mayo Clinic Footer